Oxidized Biopolymer Cross-Linking for Pathogen Inactivation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for controlling pathogens, particularly in animals, face challenges due to the rise of antibiotic-resistant diseases and the limitations of botanical extracts, which often result in undesirable side effects and environmental concerns, with a need for effective, safe, and cost-efficient alternatives to antibiotics and synthetic disinfectants.
Innovation Solution
A biochemical composition comprising a processed fluid with a polyphenol or polysaccharide derivative, activated by an oxidizing agent and catalyst, which increases binding affinity and forms oxidized biopolymers capable of cross-linking proteins and inactivating pathogens, thereby providing localized antimicrobial activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antibiotic therapies are used to control pathogens, then pathogen propagation is inhibited, but pathogen resistance develops and side effects occur
Solution Approach 1:
The patent changes the chemical state of polyphenol compounds from reduced to oxidized form through controlled oxidation processes. This parameter change transforms the molecules into highly reactive quinonic compounds that form covalent cross-links with pathogen proteins, creating a mechanism of action fundamentally different from antibiotics and thereby preventing resistance development while maintaining effective pathogen control
Solution Approach 2:
The patent creates composite biochemical systems combining oxidized polyphenols with other natural compounds such as polysaccharides, proteins, and lipids. These composite materials work synergistically to enhance antimicrobial activity while reducing individual component toxicity, providing broad-spectrum pathogen control without the resistance issues associated with conventional antibiotics
2Reliability
If botanical extracts are used as alternatives to antibiotics, then pathogen control is achieved, but undesirable side effects and environmental concerns arise
Solution Approach 1:
The patent applies preliminary controlled oxidation to polyphenol compounds before administration to convert them into their active oxidized forms. This preliminary action ensures that the compounds are ready to immediately form cross-links with pathogen proteins upon contact, enhancing effectiveness while allowing for better control of the oxidation process to minimize harmful byproducts
Solution Approach 2:
The patent extracts and isolates specific polyphenol compounds from plant sources, separating them from complex botanical matrices that may contain unwanted side effects. This extraction process allows for purification and standardization of the active components while removing potential harmful substances, thereby maintaining pathogen control effectiveness while reducing side effects
3Reliability
If systemic immune responses are activated to fight infection, then pathogen elimination is enhanced, but metabolic cost increases and fatal outcomes may occur
Solution Approach 1:
The patent segments the immune defense function by providing a localized, non-systemic antimicrobial agent that acts directly at the site of infection. The oxidized polyphenols concentrate their antimicrobial activity locally through cross-linking pathogen proteins in situ, preventing the need for a costly systemic immune response while still achieving effective pathogen elimination
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solution effectively inactivates pathogens by forming oxidized biopolymers with enhanced binding affinity, reducing pathogen propagation and promoting wound healing, while minimizing systemic immune responses and toxicity, offering a broad-spectrum antimicrobial effect with reduced risk of resistance.
Implementation Method 1
an activating mechanism to activate the molecule by oxidizing the hydroxyl group with an oxidizing agent and a catalyst
Implementation Method 2
an activating mechanism to activate the molecule by oxidizing the hydroxyl group with an oxidizing agent and a catalyst
Implementation Method 3
the high affinity o-polyphenols spontaneously form covalent intra- and inter-chain cross-links that condense proteins far more aggressively than hydrogen bonds
Data Source
Figure 1
Figure 2
Figure 3
AI summary
Methods of and compositions for producing and using plant-based materials are provided. The methods include using biopolymers or their synthetic equivalents combined with a stable source of reactive oxygen species that when applied to or combined with a separate source of oxido-reducing enzyme or catalyst will cause the formation of an activated biopolymer with increased protein binding affinity and microbial control activities.